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Zerumbone is a natural monosesquiterpene isolated from the rhizomes of Zingiber zerumbet Smith. This 
bioactive compound has been previously shown to have chemo-preventive, anti-inflammatory and free 
radical scavenging activities. This study was designed to determine the median lethal dose (LD50) of 
zerumbone and the effect of three different single doses of zerumbone below the LD50 on blood 
biochemistry, hepatic and renal histopathologies and lipid peroxidation in rats. In the LD50 experiment, 
eight groups of animals (n = 5) were injected with various doses of zerumbone (100 - 3000 mg/kg, i.p). 
The animals were observed continuously for clinical change and mortality. Next, zerumbone was 
injected in single doses (100, 200 and 500 mg/kg) and sacrificed 24 h later. Probit analysis of this study 
showed that the LD50 of this compound is 1.84 gm/Kg. Results from this study further suggested that 
single injected doses of zerumbone at 100 - 200 mg/kg had no ill effect towards the liver and renal 
tissues of female Sprague Dawley rats. To our knowledge, this paper is the first to report the toxicity 
effects of zerumbone in rodents.  
 





Traditional use of plant origin remedies for treatment of 
diseases is widely practiced in developing countries. It is 
estimated that approximately 60% of the world’s population 
relies on plants for medications. This percentage raise to 
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Abbreviations: LD50, Median lethal dose; ZER, zerumbone; 
BUN, blood urea nitrogen; ALT, alanine aminotransferase; 
ALP, alkaline phosphatase; GGT, gamma-glutamyl 
transpeptidase; MDA, malondialdehyde; H&E, haematoxylin 
and eosin staining; DMSO, dimethyl sulfoxide. 
developing world, easy access and escalating drug costs 
(Fransworth and Soejarto, 1994: Cordell, 2002). Plants, 
therefore, remain the major supplier of active drugs from 
natural sources (Ogbonnia et al., 2008), which include 
peptides, unsaturated long chain fatty acids, aldehydes, 
alkaloids, essential oils, phenols and water or ethanol 
soluble compounds. These compounds are potentially 
significant in therapeutic applications against diseases of 
diverse origins (Parvez et al., 2005; Khan et al., 2003). 
Most often, these herbal remedies recipes are used in 
most disease conditions over a long period of time 
without proper dosage monitoring and consequently toxic 
effects probably resulted from such prolonged usage. As 
such, the danger associated with the potential toxicity of 





necessitates in keeping abreast reported occurrences of 
renal and hepatic toxicities, consequential from intake of 
these medicinal herbs (Tédong et al., 2007). 
Zingiber zerumbet Smith, a plant commonly found in 
Malaysia is known locally as ‘lempoyang’ that belongs to 
the Zingiberaceae family (Abdul et al., 2008). This plant is 
used traditionally as a cure for swelling, sores and loss of 
appetite. The volatile oils of the plant rhizomes have 
shown to contain zerumbone, humulene and camprene 
(Hasnah, 1991). Zerumbone (ZER), a monosesquiterpine, 
is recognized as a main compound of this plant. This 
phytochemical has potential use as an effective 
anticancer agent, possibly by its apoptosis–inducing and 
antiproliferative influences (Siddiq et al., 2009 Kirana et 
al., 2003). Moreover, cytotoxic effects of ZER have been 
reported to be selective toward cancer cells compared to 
normal cells (Abdul et al., 2008; Matthes et al., 1980). 
Furthermore, the compound was found to work syner-
gistically with cisplatin in female cervical cancer mice, 
whereby it reduced the therapeutic dose of cisplatin used 
(Abdul et al., 2009). Therefore, the aim of this study was 
to determine the median lethal dose (LD50) and to 
evaluate the effect of single doses of zerumbone on the 
extent of tissue damages of liver and kidney in rats. 
 
 




ZER was isolated using the hydrodistillation (steam distillation) 
method. Briefly, fresh rhizomes of Z. zerumbet were initially cleaned 
and sliced and later positioned in a glass flask containing distilled 
water and heated immediately using the heating mantel. The flask 
was immediately connected to special glassware (Dienstag) in 
order to collect vaporized steam containing the volatile oil. Then 
volatile oil was crystallized using circulating cool water. The crystals 
were collected and used. To obtain highly pure ZER, recrystalization 
was performed using hexane and the solution was left standing to 
evaporate. Thin layer chromatography was used to examine 
purification of ZER at each step. The crystals of ZER were kept for 
further chemical and pharmacological analyses. 
 
 
Acute toxicity study 
 
The toxicity study was carried out using forty (40) female Sprague-
Dawley rats weighing 150 - 200 g, procured from the Animal House 
Unit, Faculty of Veterinary Medicine, University Putra Malaysia 
(UPM) were used. The animals were randomly distributed into eight 
treated groups, containing five animals per group. They were 
allowed to acclimatize to the laboratory conditions for seven days 
before the experiment and they were allowed to fast by withdrawing 
food and water for 18 h. Each group of animals was injected with 
various doses of 100, 200, 500, 1000, 1500, 2000, 2500 and 3000 
mg/kg body weight (b. wt.) of zerumbone intraperitoneally. Animals 
were provided with food and water immediately after injecting the 
compounds. The animals were observed continuously for the first 4 
h and then each hour for the next 24 h and at 6 hourly intervals for 
the following 48 h after administering of the extract, to observe any 
death or changes in general behavior and other physiological 
activities (Shah et al., 1997; Bürger et al., 2005). Acute LD50 of the 
compound was calculated using software for probit analysis. 




Effect of the single doses of zerumbone 
 
Thirty (30) female rats (Sprague Dawley) of 180 - 200 g weight, 
procured from the Animal House Unit, Faculty of Veterinary 
Medicine, university Putra Malaysia (UPM) were used. The animal 
room at Institute Bioscience, UPM was maintained at a temperature 
of 25 ± 2°C with a 12 h light/dark cycle and a relative humidity of 50 
- 60%. Free access to food and water was allowed at all times. Rats 
were housed five per cage in sterilized plastic cages using 
homogenized wood shavings as bedding. All experimental protocols 
held on animals were done according to regulations set by The 
Institutional Animal Care and Use Committee, Faculty of Medicine 
and Allied Sciences, UPM. Rats were divided into five groups:  
 
- Group 1 animals were induced a single intrapreitoneal injection of 
500 mg/kg zerumbone. 
- Group 2 animals were given a single intrapreitoneal injection 200 
mg/kg zerumbone. 
- Group 3 animals were induced a single intrapreitoneal injection 
100 mg/kg zerumbone. 
- Group 4 were being as a negative control. 
- Group 5 was a positive control, animals were induced a single 
intrapreitoneal injection cisplatin 10 mg/kg either DMSO as a 
vehicle for 24 injection.  
 
The rats were killed under ether anesthesia; one hour after injection 
and blood, kidney and liver tissues were then collected. Trunk blood 
was collected and analyzed for serum creatinine and blood urea 
nitrogen (BUN) and ALT, ALP and GGT serum’s levels. After 
bleeding, tissues samples were removed and fixed in 10% 
formaldehyde for histopathological examinations or stored at -80°C 
for measurement of malondialdehyde (MDA). 
 
 
Determination of kidney and liver functions 
 
As indicators of kidney function, serum creatinine and BUN Levels 
were measured. Serum ALT, AST, ALP and GGT levels were 
measured to evaluate the liver function.  All biochemical assays 
were performed spectrophotometrically using Hitachi-912 Autoanalyser 
(Mannheim, Germany) with kits were supplied by Roche Diagnostics 
(Mannheim, Germany). To obtain data with good sensitivity and 






Animal tissues were fixed in 10% formalin. The kidney and liver 
samples were embedded in parafin and sectioning at 5 µm will stain 
with hematoxylin-eosin. All sections were examined using a 
photomicroscope (Olympus BH-2, Japan). The renal injury was 
based on degeneration of Bowman space and glomeruli, 
degeneration of proximal and distal tubuli, vascular congestion and 
interstitial edema. The criteria for liver injury were vacuolization of 
hepatocytes and pyknotic hepatocyte nuclei, activation of Kupffer 
cells and enlargement of sinusoids. Each specimen was score 
using a scale ranging from 0 - 3 (0: none, 1: mild, 2: moderate, and 
3: severe) for each criterion. The total score was 9 for both kidney 
and liver. Histological examination and scoring were performed by 
an observer (F.E.) unaware of the treatment groups.  
 
 
Measurement of tissue MDA 
 
Levels of MDA were assayed by the method of Satoh (Satoh, 
1978). Briefly, 10% (weight/volume) homogenate of kidney and liver  




Table 1. The number of female Sprague Dawley rats death following 
single injected doses of zerumbone. 
 
Doses Mortality Survivors (%) Total 
0    
100   100 5/5 
200  100 5/5 
500   100 5/5 
1000  100 5/5 
1500 1 80 4/5 
2000 2 60 3/5 
2500 5 0 0/5 




Table 2. Rats serum kidney markers quantified following injected dose of 
cisplatin and single injected doses of zerumbone and control.  
 





ZER500 mg/kg  74.17 24.06 
ZER 200 mg/kg  62.40 12.10 
ZER 100 mg/kg  66.00 20.57 
Corn Oil Negative Control 54.80 18.27 





ZER 500 mg/kg  8.90 2.64 
ZER 200 mg/kg  6.54 2.12 
ZER 100 mg/kg  7.55 2.51 
Corn Oil Negative Control 6.16 2.01 
Cisplatin 10 mg/kg  10.27* 0.40 
 
CREAT: creatinine; BUN: blood urea nitrogen; Data are means ± SD of five rats for 




were made by 0.1 mol/L phosphate buffer was centrifuged at 4°C; 
3500 rpm for 10 min. 0.2 mL supernatant was mixed with 0.67% 2-
thiobarbituric acid (TBA) and 20% trichloroacetic acid solution, and 
heated in a boiling water bath for 30 min. The pink-colored 
chromogen was formed by the reaction of TBA with MDA will 
measure at 532 nm. The results were expressed as MDA nmol/mg 
protein. Contents of protein in the supernatant were measured by 





All data are expressed as mean ± SD. Histological data (Lesion 
Scoring) were compared using Kruskal- Wallis non-parametric test 
whilst other parameters were compared by one-way ANOVA 
followed by post hoc Tukey HSD multiple comparison tests. The 
type one error level was set at p < 0.05 for all tests. All statistical 
analyses were performed using SPSS software (Chicago, IL, USA) 







In  the acute  toxicity  study  (Table 1),  100%  death  was  
observed for all the animals that received 2500 and 3000 
mg/kg of the compound whilst 20 and 40% death for 
animals that received 1500 and 2000 mg/kg, respectively. 
There was no death in the animals that received 100, 
200, 500 and 1000 mg/kg. The median acute toxicity 
(LD50) of the compound was determined to be 1.84 g/kg. 
 
 
Effect of single doses of zerumbone on the kidney 
and liver functions 
 
Results of this study showed that single dose of 500 
mg/kg zerumbone caused a significant reduction in renal 
and hepatic function, as characterized by remarkable 
increased in serum creatinine and (BUN) and ALT, ALP 
and GGT levels (Tables 2 and 6). These findings indicate 
strongly that single intra-peritoneal injection of 500 mg/kg 
of zerumbone caused abnormalities to the renal and 
hepatic functions. 
Treatment with other single doses of 100 and 200 mg/kg 
zerumbone for 24 h however did not induce any 
abnormalities   in  the  serum  creatinine  and  (BUN)  and  




Table 3. Lesions scoring scored in rat kidney tissues of injected cisplatin and single injected doses of zerumbone and 
control. 
 
Lesions Single doses Mean S.D 
Degeneration of Bowman space and glomeruli ZER 500 mg/kg  1.27 0.41 
ZER 200 mg/kg  0.57 0.19 
ZER 100 mg/kg  0.70 0.22 
Cisplatin10 mg/kg  3.00* 1.00 
Corn Oil Negative 
Control  
0.00 0.05 
Degeneration of proximal and distal tubuli ZER 500 mg/kg  1.10 0.548 
ZER 200 mg/kg  0.62 0.20 
ZER 100 mg/kg  0.93 0.31 
Cisplatin10 mg/kg  3.00* 1.00 
Corn Oil Negative 
Control  
0.00 0.05 
Vascular congestion and interstitial edema ZER 500 mg/kg  1.41 0.41 
ZER 200 mg/kg  0.33 0.11 
ZER 100 mg/kg  0.44 0. 21 
Cisplatin10 mg/kg  3.00* 1.00 








Table 4. Malondialdehyde (MDA) levels determined in rat 
kidney tissues following injected dose of cisplatin and 
single injected doses of zerumbone and control. 
 
Treatments Mean SD 
ZER500 mg/kg 1.01 0.20 
ZER 200 mg/kg  0.62 0.12 
ZER 100 mg/kg  0.83 0.21 
Corn Oil Negative Control 0.50 0.01 
Cisplatin 10 mg/kg  2.76* 0.16 
 
Data are means ± SD. of five rats for each group. * 




ALT, ALP and GGT levels. In addition to this, DMSO and 
corn oil did not induce any abnormal changes in serum 
levels of kidney and liver enzymes (Tables 2 and 6). 
 
 
Effect of single doses of zerumbone on qualitative 
and quantitative histopathology   and clinical 
observation 
 
No death was observed amongst all animal groups during 
the period of this study. Tissue samples were obtained 
and observed under microscopy. Tissues in the single 
dose of zerumbone 500 mg/kg administered animals have 
shown cellular damage. Renal damage was recognized 
by severe degeneration in glomeruli and tubuli (both 
proximal and distal tubuli) while hepatic damage was 
recognized by severe activation of Kupffer cells, dege-
neration, and moderate enlargement of sinusoids. In the 
single dose of 200 mg/kg zerumbone treated animals, the 
morphology of the tissues is near normal. The 
morphological feature of the tissues from the 100 mg/kg 
zerumbone injected animals is similar to the control 
morphology, which revealed normal and regular appearance 
of glomeruli and tubuli and normal hepatocytes, Kupffer 
cells and sinusoids (Figures 1 and 2A - G). With reference 
to the morphological appearance of the tissues from 500 
mg/kg zerumbone injected animals, their quantitative 
lesions scoring mean is statistically higher than that of 
normal control group (p < 0.05). 100 and 200 mg/kg 
zerumbone administration did not show microscopic 
lesion scoring effectively (p < 0.05) (Tables 3 and 6).  
Total mean scoring, degeneration of Bowman space 
and glomeruli, degeneration of proximal and distal tubuli, 
vascular congestion and interstitial edema and sinusoidal 
dilatation, activation of kupffer cells and vacuolization was 
used as indices to evaluate the lesions quantitatively. In 
respect to these indices, the highest mean was observed 
in the single dose of 500 mg/kg zerumbone and 10 mg/kg 
cisplatin treated animal groups. 
 
 
Effect of single doses of Zerumbone on MDA level 
 
Lipid peroxidation in the tissues was evaluated using 
measurements of MDA  levels  quantitively. In  500 mg/kg  




Table 5. Effect towards rats serum liver function enzymes following injected dose of cisplatin 
and single injected doses of zerumbone and control.  
 






ZER 500 mg/kg  88.98 22.3 
ZER 200 mg/kg  63.96 18.00 
ZER 100 mg  62.77 18.20 
Corn Oil Negative Control 60.34 19.05 






ZER 500 mg/kg  272.83 66.41 
ZER 200 mg/kg  250.40 42.00 
ZER 100 mg/kg  248.67 42.09 
Corn Oil Negative Control 243.80 67.52 






ZER 500 mg/kg  3.33 0.52 
ZER 200 mg/kg  2.06 0.35 
ZER 100 mg/kg  1.83 0.61 
Corn Oil Negative Control 1.00 0.21 
CISPLATIN 10 mg/kg  5.00* 1.30 
 
ALT: Alanine aminotransferase; ALP: Alkaline Phosphatase; GGT: Gamma-glutamyl transpeptidase 
Data are means ± SD of five rats for each group. 




Table 6. Lesions scoring scored in rat liver tissues of injected dose of cisplatin and single injected 
doses of zerumbone and control. 
 
Lesions Doses Mean S.D 
Activation of Kupffer cells ZER 500 mg/kg  2.00 0.45 
ZER 200 mg/kg  0.32 0.06 
ZER 100 mg/kg  0.29 0.09 
Corn Oil Negative Control  0.20 0.05 
Cisplatin 10 mg/kg  3.00* 1.00 
Sinusoidal dilatation ZER 500 mg/kg  1.20 0.40 
ZER 200 mg/kg  0.83 0.21 
ZER 100 mg/kg  0.79 0.20 
Corn Oil Negative Control  0.40 0.12 
CISPLATIN10 mg/kg  3.00* 0.90 
Vacuolization ZER 500 mg/kg  1.90 0.61 
ZER 200 mg/kg  1.09 0.33 
ZER 100 mg/kg  1.07 0.35 
Corn Oil Negative Control  0.00 0.00 
CISPLATIN 10 mg\kg  3.00* 0.08 
 




zerumbone and cisplatin injected animals, MDA level is 
significantly higher compared to normal control (P < 
0.05). Treatment with the single doses of 100 and 200 
mg/kg zerumbone did not show any abnormal levels of 
MDA (Tables 4 and 7).  
DISCUSSION 
 
Herbal medicines are now being received recently as 
alternatives to synthetic pharmaceutical products, thus 
leading to an increased to their demand as natural 






Figure 1. Photomicrographs of rat kidney tissue samples of injected 10 mg/kg cisplatin, 100, 200 and 500 mg/kg ZER-
treated animal groups. Control groups (E), (F): normal histological appearance of kidney. 10 mg/kg cisplatin group (A): 
severe glomerular congestion and degeneration, dilatation in Bowman’s space, and degeneration in tubular cells in 
kidney. 200 and 100 mg/kg ZER Group (C), (D): normal histological appearance of kidney. 500 mg/kg ZER Group (B): 
Moderate degeneration of Bowman space and glomerular congestion. Moderate tubular degeneration in tubular cell: 
Hematoxylin–eosin staining, Original magnifications: ×200. A-CISPLATIN 10 mg/kg. A1 Severe degeneration of Bowman 
space and glomerular congestion. A2- Severe degeneration in tubular cells. B-ZER 500 mg/kg. B1- Moderate 
degeneration of Bowman space and glomerular congestion. B2- Moderate degeneration of tubular cells. C-ZER 100 
mg/kg. C1- Normal histological appearance of Bowman space and glomeruli. C2- Normal histological appearance of 
tubular cells. D-ZER 200 mg/kg control. D1- Normal histological appearance of Bowman space and glomeruli. D2- Normal 
histological appearance of tubular cells. E-  Nagative control DMSO. E1- Normal histological appearance of Bowman   
space and glomeruli. E2- Semi normal histological appearance of tubular cells. F-Negative control corn oil. F1- Normal 




medicine (Mythilypriya et al., 2007). World Health Organi-
zation (WHO) survey indicated that about 70 - 80% of the 
world’s populations rely on traditional medicine, mainly 
herbal source, as their primary healthcare (Dyson, 1998; 
Chan, 2003). Although medicinal plants produced several 
biological activities that are useful, very few or none is 
known regarding their toxicities in humans. As such, the 
inclusion of toxicological evaluation at preclinical stage 
will assure its safe usage in humans as a medicine 
(Tomlinson and Akerele, 1998). Similarly to this context 
and in the present study, the natural compound zerumbone 
isolated from Z. zerumbet, belonging to the Zingiberaceae 
plant family was subsequently evaluated toxicologically in 
rats,   principally   for   safe  usage  intended  as  a  future  
medicine in humans. 
Several dietary ingredients of the Zingiberaceae family 
have been reported and their biological activities 
elucidated (Aggarwal and Shishodia, 2006; Surh, 1999). 
In this respect, zerumbone is used initially as an anti-
inflammatory adjuvant for sprain and in treating human 
ailments (Chiu and Chang, 1986). Several reports on the 
bioactivities of zerumbone have been recently reported, 
which included anticarcinogenesis (Takada et al., 2005), 
anti-inflammation (Murakami et al., 2003) and most 
recently from our own laboratory, zerumbone’s anticancer 
effect on cervical tissues (Abdul et al., 2009). However, 
despite several evidences of its biological activities and 
therapeutic   benefits,   there    has   been    no    reported  






Figure 2. Photomicrographs of liver samples of the control, cisplatin, and 100, 200, 00 mg/kg ZER treated animal groups. 
Control group (E), (G): normal histological appearance of liver. Cisplatin group (A): severe degenerated hepatocytes 
sever haemorrhage inside hepatocytes and increased number of activated Kupffer cells. 100 mgZER group (D) mild 
degenerated hepatocytes and increased number of activated Kupffer cells. 200 mgZER group (C) mild degenerated 
hepatocytes and increased number of activated Kupffer cells: Hematoxylin–eosin staining, original magnifications: ×200. 
A-CISPLATIN 10 mg \kg. A1 -Severe degenerated hepatocytes (vacuolization). A2- Severe haemorrhage inside 
hepatocytes. A3- Increased number of activated Kupffer cells. B-ZER 500 mg\kg. B1- Increased number of activated 
Kupffer cells. B2- Mild degenerated hepatocytes (vacuolization). C- ZER 200 mg\kg. C1- Increased number of activated 
Kupffer cells. C2- Mild degenerated hepatocytes (vacuolization). (Semi normal histological appearance of liver). D- ZER 
100 mg\ kg. D1- Increased number of activated Kupffer cells. D2- Mild degenerated hepatocytes (vaiocuolizatn). (Near 
normal histological appearance of liver). E-DMSO negative control. E1- Normal number of activated Kupffer cells. Normal 
histological appearance of liver. F- Corn oil negative control. F1- Normal number of activated Kupffer cells; normal 




toxicological evaluation performed to this compound in 
vivo. 
Toxicologically, acute toxicity investigation is the initial 
step towards toxicological analysis of herbal drugs. In 
relation to this, this report is the first to provide scientific 
data on acute toxicity effect of zerumbone in vivo. In this 
regard, our data showed that a single dose given intra-
peritoneally up to 1000 mg/kg in rats did not produce any 
mortality. The LD50 of zerumbone is found to be 1.84 g/ 
kg. Base on the classification of Loomis and Hayes (1996), 
this suggests that substances having LD50 between 500 
and 5000 mg/kg bodyweight are regarded as being 
slightly toxic and practically non-toxic, the present findings 
showed that zerumbone safety falls between these two 
values of being almost practically non-toxic. 
Single doses effect of zerumbone on the kidney and 
liver function was carried out to evaluate the nephro-
toxicity and hepatotoxicity of this compound onfemale 
Sprague Dawley rats. During kidney and liver cell 
damaged, creatinine and blood urea nitrogen (BUN) 
together with ALT, ALP and GGT enzymes leak out, 
causing blood levels of these chemical components and 
enzymes to rise. Increased levels of these chemical 
components and enzymes in blood are  considered  good  




Table 7. Malondialdehyde (MDA) levels determined in rat liver tissues 
following injected dose of cisplatin and single injected doses of 
zerumbone and control. 
 
Treatments Mean SD 
ZER 500 mg/kg  5.38 1.56 
ZER 200mg/kg  2.84 0.91 
ZER 100mg/kg  2.60 0.84 
Corn Oil Negative Control 2.74 0.89 
Cisplatin10mg/kg  6.81* 2.06 
 





indicators for kidney and liver cell damage. In this present 
study, our result showed significant difference in plasma 
creatinine and blood urea nitrogen (BUN) and ALT, ALP 
and GGT enzymes between single injected dose of 500 
mg/kg zerumbone to 10 mg/kg cisplatin groups (p < 
0.05). The later showing higher blood levels of both 
kidney and liver biomarkers comparatively to the injected 
zerumbone group. 
In addition, our findings also indicate no nephrocellular 
and hepatocellular injury in the other single injected 
doses of 100 and 200 mg/kg zerumbone. This was later 
confirmed by histological examinations of tissue sections 
using H & E staining of light microscope and MDA levels 
in rat’s kidney and liver tissues. Results from this study 
suggested that single injected doses of zerumbone at 
100 - 200 mg/kg had no ill effect on the kidney and liver 





The LD50 value (1.84 g/kg) obtained was a clear indication 
that zerumbone could be safe for use in one dose 
treatment. The study also revealed that the compound at 
low and moderate doses did not incite toxic effects in the 
animals’ tissues. On the contrary, higher doses of 500 
mg/kg zerumbone induced nephrocellular and hepato-
cellular damage, leading to renal and hepatic failure. Our 
study also showed that the liver and kidney function tests 
are useful markers to monitor during treatment in using 
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